William Damsky MD
Dermatopathology
Assistant Professor of Dermatology and Pathology
Join to View Full Profile
428 Columbus AveNew Haven, CT 06519
Phone+1 203-503-3000
Fax+1 203-785-7637
Dr. Damsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2014
University of Vermont College of MedicineClass of 2013
Certifications & Licensure
FL State Medical License 2022 - Present
CT State Medical License 2017 - 2025
American Board of Dermatology Dermatology- American Board of Dermatology Dermatopathology
Clinical Trials
- Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Start of enrollment: 2019 Apr 11
- Janus Kinase Inhibition in Sarcoidosis Start of enrollment: 2023 Jun 01
Roles: Principal Investigator, Contact
- Janus Kinase Inhibition in Granuloma Annulare Start of enrollment: 2023 Oct 27
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- Bipolar disorder among individuals with atopic dermatitis: a case-control study in the All of Us Research Program.Anthony Mitchel Wride, Gloria F Chen, Ryan Fan, Audrey C Leasure, Stephen Scott Jones
Clinical and Experimental Dermatology. 2025-03-26 - Spatial Transcriptomics Reveals Differential Inflammatory Pathways in Discoid Lupus Erythematosus and Lichen Planus.Michal Kidacki, Christina Cho, Francesc Lopez-Giraldez, Rachel Breidbart, Anjali Jaiswal
The Journal of Investigative Dermatology. 2025-03-18 - 3 citationsEffects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response.Yufeng Lin, Mingxu Xie, Harry Cheuk-Hay Lau, Ruijie Zeng, Ruyi Zhang
Med. 2025-03-14
Press Mentions
Novel LDTs Advance Dermatological DiagnosticsFebruary 14th, 2025- TNF or JAK: Which Target Is Key to Success in Tough-to-Treat Skin Disease?November 11th, 2021
- Dramatic Responses in Cutaneous Sarcoidosis with JAK InhibitorNovember 7th, 2021
- Join now to see all
Grant Support
- Delineation of the immunobiology of sarcoidosis and characterization of the effects of Janus kinase inhibitionYALE UNIVERSITY2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
